316 related articles for article (PubMed ID: 32296163)
21. Laboratory perspectives in the development of polygenic risk scores for disease: A points to consider statement of the American College of Medical Genetics and Genomics (ACMG).
Reddi HV; Wand H; Funke B; Zimmermann MT; Lebo MS; Qian E; Shirts BH; Zou YS; Zhang BM; Rose NC; Abu-El-Haija A;
Genet Med; 2023 May; 25(5):100804. PubMed ID: 36971772
[No Abstract] [Full Text] [Related]
22. Clinical utility of polygenic risk scores for embryo selection: A points to consider statement of the American College of Medical Genetics and Genomics (ACMG).
Grebe TA; Khushf G; Greally JM; Turley P; Foyouzi N; Rabin-Havt S; Berkman BE; Pope K; Vatta M; Kaur S;
Genet Med; 2024 Apr; 26(4):101052. PubMed ID: 38393332
[No Abstract] [Full Text] [Related]
23. Points to consider: is there evidence to support BRCA1/2 and other inherited breast cancer genetic testing for all breast cancer patients? A statement of the American College of Medical Genetics and Genomics (ACMG).
Pal T; Agnese D; Daly M; La Spada A; Litton J; Wick M; Klugman S; Esplin ED; Jarvik GP;
Genet Med; 2020 Apr; 22(4):681-685. PubMed ID: 31831881
[No Abstract] [Full Text] [Related]
24. Direct-to-consumer prenatal testing for multigenic or polygenic disorders: a position statement of the American College of Medical Genetics and Genomics (ACMG).
ACMG Board of Directors
Genet Med; 2021 Nov; 23(11):2027-2028. PubMed ID: 34183790
[No Abstract] [Full Text] [Related]
25. Prenatal Detection of Uniparental Disomies (UPD): Intended and Incidental Finding in the Era of Next Generation Genomics.
Eggermann T
Genes (Basel); 2020 Dec; 11(12):. PubMed ID: 33287348
[TBL] [Abstract][Full Text] [Related]
26. Points to consider in the detection of germline structural variants using next-generation sequencing: A statement of the American College of Medical Genetics and Genomics (ACMG).
Raca G; Astbury C; Behlmann A; De Castro MJ; Hickey SE; Karaca E; Lowther C; Riggs ER; Seifert BA; Thorland EC; Deignan JL;
Genet Med; 2023 Feb; 25(2):100316. PubMed ID: 36507974
[No Abstract] [Full Text] [Related]
27. The use of fetal exome sequencing in prenatal diagnosis: a points to consider document of the American College of Medical Genetics and Genomics (ACMG).
Monaghan KG; Leach NT; Pekarek D; Prasad P; Rose NC;
Genet Med; 2020 Apr; 22(4):675-680. PubMed ID: 31911674
[No Abstract] [Full Text] [Related]
28. The designated record set for clinical genetic and genomic testing: A points to consider statement of the American College of Medical Genetics and Genomics (ACMG).
Tayeh MK; Chen M; Fullerton SM; Gonzales PR; Huang SJ; Massingham LJ; O'Daniel JM; Stewart DR; Stiles AR; Evans BJ;
Genet Med; 2023 Mar; 25(3):100342. PubMed ID: 36547466
[No Abstract] [Full Text] [Related]
29. Response to "The use of ACMG secondary findings recommendations for general population screening: a policy statement of the American College of Medical Genetics and Genomics (ACMG)".
Nussbaum RL; Haverfield E; Esplin ED; Aradhya S
Genet Med; 2019 Dec; 21(12):2836-2837. PubMed ID: 31239557
[No Abstract] [Full Text] [Related]
30. Robertsonian translocations: mechanisms of formation, aneuploidy, and uniparental disomy and diagnostic considerations.
Kim SR; Shaffer LG
Genet Test; 2002; 6(3):163-8. PubMed ID: 12490055
[TBL] [Abstract][Full Text] [Related]
31. Stewardship of patient genomic data: A policy statement of the American College of Medical Genetics and Genomics (ACMG).
Best RG; Khushf G; Rabin-Havt SS; Clayton EW; Grebe TA; Hagenkord J; Topper S; Fivecoat J; Chen M; Grody WW;
Genet Med; 2022 Mar; 24(3):509-511. PubMed ID: 35253644
[No Abstract] [Full Text] [Related]
32. CCMG guidelines: prenatal and postnatal diagnostic testing for uniparental disomy.
Dawson AJ; Chernos J; McGowan-Jordan J; Lavoie J; Shetty S; Steinraths M; Wang JC; Xu J;
Clin Genet; 2011 Feb; 79(2):118-24. PubMed ID: 21039433
[TBL] [Abstract][Full Text] [Related]
33. Case report: A case of novel homozygous LRBA variant induced by chromosomal segmental uniparental disomy - genetic and clinical insights.
Jiang L; Chen S
Front Immunol; 2024; 15():1351076. PubMed ID: 38504982
[TBL] [Abstract][Full Text] [Related]
34. The use of ACMG secondary findings recommendations for general population screening: a policy statement of the American College of Medical Genetics and Genomics (ACMG).
ACMG Board of Directors
Genet Med; 2019 Jul; 21(7):1467-1468. PubMed ID: 31019278
[No Abstract] [Full Text] [Related]
35. Pediatric clinical exome/genome sequencing and the engagement process: encouraging active conversation with the older child and adolescent: points to consider-a statement of the American College of Medical Genetics and Genomics (ACMG).
Bush LW; Bartoshesky LE; David KL; Wilfond B; Williams JL; Holm IA;
Genet Med; 2018 Jul; 20(7):692-694. PubMed ID: 29565417
[No Abstract] [Full Text] [Related]
36. Risk estimates for uniparental disomy following prenatal detection of a nonhomologous Robertsonian translocation.
Shaffer LG
Prenat Diagn; 2006 Apr; 26(4):303-7. PubMed ID: 16491515
[TBL] [Abstract][Full Text] [Related]
37. Prenatal genetic testing for a microdeletion at chromosome 14q32.2 imprinted region leading to UPD(14)pat-like phenotype.
Sasaki A; Sumie M; Wada S; Kosaki R; Kurosawa K; Fukami M; Sago H; Ogata T; Kagami M
Am J Med Genet A; 2014 Jan; 164A(1):264-6. PubMed ID: 24259232
[No Abstract] [Full Text] [Related]
38. ACMG SF v3.0 list for reporting of secondary findings in clinical exome and genome sequencing: a policy statement of the American College of Medical Genetics and Genomics (ACMG).
Miller DT; Lee K; Chung WK; Gordon AS; Herman GE; Klein TE; Stewart DR; Amendola LM; Adelman K; Bale SJ; Gollob MH; Harrison SM; Hershberger RE; McKelvey K; Richards CS; Vlangos CN; Watson MS; Martin CL;
Genet Med; 2021 Aug; 23(8):1381-1390. PubMed ID: 34012068
[No Abstract] [Full Text] [Related]
39. ACMG SF v3.2 list for reporting of secondary findings in clinical exome and genome sequencing: A policy statement of the American College of Medical Genetics and Genomics (ACMG).
Miller DT; Lee K; Abul-Husn NS; Amendola LM; Brothers K; Chung WK; Gollob MH; Gordon AS; Harrison SM; Hershberger RE; Klein TE; Richards CS; Stewart DR; Martin CL;
Genet Med; 2023 Aug; 25(8):100866. PubMed ID: 37347242
[TBL] [Abstract][Full Text] [Related]
40. ACMG SF v3.1 list for reporting of secondary findings in clinical exome and genome sequencing: A policy statement of the American College of Medical Genetics and Genomics (ACMG).
Miller DT; Lee K; Abul-Husn NS; Amendola LM; Brothers K; Chung WK; Gollob MH; Gordon AS; Harrison SM; Hershberger RE; Klein TE; Richards CS; Stewart DR; Martin CL;
Genet Med; 2022 Jul; 24(7):1407-1414. PubMed ID: 35802134
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
